GOVX @ .06: Awarded $658,000 HIV grant via NIH Roughly 20% of market cap. In addition, Zika grant is also due. GOVX a low floater (in regard to otcbb). Imo, the single biggest bang for the buck in bio/pharma right now. Link: http://finance.yahoo.com/news/geovax-awarded-658-000-nih-130000118.html